What is the real contribution of comorbid conditions? Source: Annual Congress 2007 - Severe asthma: what are the crucial targets? Year: 2007
CF diagnosis in adulthood: a greater prevalence of classical forms than expected? Source: Eur Respir J 2006; 28: Suppl. 50, 716s Year: 2006
The influence of different schemes of basic treatment on functional indices in moderate–severe asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 54s Year: 2006
Is there evidence showing that real-life aspects (comorbid conditions, inhaler technique, and lifetstyle factors) influence asthma management? Source: International Congress 2014 – The evolving role of real-life research in respiratory medicine Year: 2014
Chronic bronchitis in the general population: role of socio-economic conditions Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009
COPD phenotypes and co-morbidities: to what extent do they affect a successful response to rehabilitation? Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011
Is the strength of the type-2 (T2) inflammatory biomarker signal important in determining the burden of disease in severe asthma (SA)? Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020
Influence of different conditions on asthma severity Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma Year: 2007
The influence of early life events on adult lung function: a mechanism to explain the high rates of chronic respiratory disease seen in populations undergoing a demographic transition Source: Eur Respir J 2001; 18: Suppl. 33, 506s Year: 2001
Defining non-T2 asthma: moving beyond the absence of T2 activity Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players? Year: 2019
Frequency and pecularities of flow pulmonary tuberculosis (PT) in patients with different forms of diabetes mellitus (DM) in up-to-date conditions Source: Eur Respir J 2002; 20: Suppl. 38, 363s Year: 2002
Genotype, phenotype and the environment in respiratory diseases: what contributes the most? Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012
Is a positive response to a pulmonary rehailitation programme associated with a longer persistence of the improvement? Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease Year: 2009
COPD: Different psychology status (PS) in the patients with different co-morbidity rate Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Effects of differences in exposure conditions on pulmonary functions Source: Annual Congress 2012 - COPD beyond tobacco Year: 2012
Sex and hormonal influence on asthma phenotypes: the case in favour Source: Virtual Congress 2021 – Highlights on gender and respiratory health Year: 2021
Comparing asthma rates across regional environments: is spatial modelling possible and plausible? Source: Eur Respir J 2005; 26: Suppl. 49, 139s Year: 2005
Gender differences in airway behaviour (physiology) over the human lifespan Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=8 Year: 2003
COPD: Different psychology status (PS) in patients with different cardiac co-morbidities rate Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
The lower limit of normal versus a fixed ratio to assess airflow limitation: will the debate ever end? Source: Eur Respir J, 51 (3) 1800403; 10.1183/13993003.00403-2018 Year: 2018